- Home
- /
- About TargetCancer Foundation
- /
- News & Updates
News & Updates
TCF In the News
Rare Cancers - Limited Treatments, Limited Research, Tons of Advocacy
TCF-001 TRACK : A Clinical Trial Studying Precision Medicine in Rare Cancers
Kelly, House Cancer Caucus co-chairs introduce resolution to recognize September 30 as 'Rare Cancer Day'
Creating a Public-Private Partnership to Support Development of Anti-Cancer Therapies for Ultra-Rare Tumor Indications
Leveraging Technology to Streamline Biomarker Testing
Luminary Awards Honor GI Experts, Patient Advocate
Target Cancer Foundation Gala returns to raise money for fight against rare cancers
Local foundation building hope for families facing rare cancer diagnosis
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial - Conquer: the journey informed
TargetCancer Foundation Enrolls First Patient to Decentralized, Rare Cancer TRACK Study
Grief and Survival Sit Side by Side
Research Advocates, Leading Docs to Expand Precision Medicine Access With Decentralized Model
Foundation Medicine, TargetCancer Foundation to test 'precision medicine'
TargetCancer Foundation Announces Rare Cancer Precision Medicine Research Initiative
TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers
Rare Cancers are Common, So Why the Lack of Research Funding?
Mark Your Calendars- October 1 is Rare Cancer Day
Funding a Hopeful Future for Rare Cancer Research
Over coffee, a research collaboration is born
Dancing to Live
Targeting Rare Cancers for Research and Treatment
Cancer Benefit Targets Hope and Healing
Dean & Britta to play TargetCancer benefit
News in Brief: TargetCancer, ATP, Parenthetical Girls, and Unthanks
News from TCF
Reflections on 15 Years of TargetCancer Foundation
This milestone of TargetCancer Foundation’s 15 year anniversary has stopped me in my tracks. It is a long time to be doing this work and a long time to grieve someone. I was shocked to realize that I have now crossed the threshold of grieving the loss of my husband...
2023: An Impactful Year In Review
RESEARCH → TCF-001 TRACK Our fully remote, decentralized precision medicine clinical trial has enrolled 157 patients with 40 rare cancers from 41 states, providing key personalized data to inform treatments. → A recent publication highlighted TRACK as an...
Thank you to our Community Fundraisers!
February is Cholangiocarcinoma Awareness Month. We are proud to highlight the many efforts from TCF community members who are working to bring attention to cholangiocarcinoma and other rare cancers in their own communities. Christina Tuskan, Indiana...
TCF Executive Director Jim Palma to Receive the 2022 Ruesch Center Luminary Award in GI Cancers
We are incredibly proud to announce that our Executive Director Jim Palma has been named a Ruesch Center 2022 Luminary Awards in GI Cancer recipient! The Luminary Awards honor individuals who have made transformative strides in the lives of patients with GI...